Global Cartilage Degeneration Market Is Expanding At A CAGR Of 5.7% Over The Next Five Years – Press Release
[ad_1]
The most recent Fact.MR research on the Cartilage Degeneration Market provides a comprehensive analysis of the market. It provides trustworthy data on the market for Vestibular Testing Systems’ drivers, restraints, challenges, and opportunities. Aside from that, the research provides a thorough picture of the demands and consumption of various products/services connected to the growth dynamics of the Cartilage Degeneration Market from 2016 to 2021.
At a CAGR of 5.7% over the following five years, the global cartilage degeneration market is projected to grow from its current value of US$ 12.1 billion in 2022 to US$ 16 billion by the end of 2027.
The demand for joint replacements is anticipated to grow at the greatest CAGR of any procedure—6%—due to an increase in joint replacement surgeries performed globally.
Click Here To get a Sample Report (Including Full TOC, Table & Figures):-https://www.factmr.com/connectus/sample?flag=S&rep_id=7738
Competitive Landscape
Top companies in the cartilage degeneration industry are focusing on creating novel cartilage repair and restoration products to increase their business potential.
- Cytonics, a biotechnology research and development company specializing in therapeutics for osteoarthritis is focusing on creating a blood protein that blocks destructive enzymes that cause degeneration of cartilage tissue. The CYT-108 is an advanced genetically engineered variant of Alpha -2-macroglobulin, a blood protein that helps in cartilage repair by blocking out destructive enzymes.
Companies in the cartilage degeneration market are also focusing on obtaining new approvals for their products to enhance their market presence and drive revenue generation capacity.
- In March 2022, CartiHeal Ltd., an Israel-based developer of implants for the treatment of cartilage defects announced that its Agili-C™ implant was granted Premarket Approval (PMA) by the U.S. FDA (Food and Drug Administration). The approval was based on the results of a two-year IDE clinical study.
Need More information about Report Customization? Click here:-https://www.factmr.com/connectus/sample?flag=RC&rep_id=7738
Key Segments in Cartilage Degeneration Industry Research
-
By Procedure :
- Joint Replacements
- Chondroplasty
- Osteochondral Transplants
- Microfracture
- Meniscus Transplants
- Cell-based Cartilage Resurfacing
- Autologous Chondrocyte Implantation
- Others
-
By Treatment Delivery Channel :
- Hospitals
- Academic & Research Institutes
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
-
By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
To get all-in insights on the regional landscape , buy now:-https://www.factmr.com/checkout/7738
This paper provides the reader with insights and analyses on the following topics:
Recent recommendations in key sectors are influencing overall demand in the Cartilage Degeneration Market.
Detailed profiles of various organisations in this market
Important trends highlight high investments by major shareholders in a variety of countries.
Consumer preferences are changing, and the latest trends in major industries are emerging.
Recent investment prospects in many technological and product/service categories
Variable demand and consumption of various product segments
The insights and projections provided in this study are the result of extensive research by Factmr analysts. This report’s unique approach and excellent guidance will assist players in understanding the growth dynamics of the Cartilage Degeneration Market.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: [email protected]
This content is published on behalf of the above source. Please contact them directly for any concern related to the above.
This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.
[ad_2]
Source link
